Drugs / ZYG24004
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07668999 | Jul 2026 → Jun 2027 expected | tinea pedis | Sinomune Pharmaceutical Co., Ltd | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZYG24004 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07668999 ↗ |
| Route | Topical | “ZYG24004 1% (4 g:40 mg) topical film-forming formulation.” NCT07668999 ↗ |